| Title |
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
|
|---|---|
| Published in |
Infectious Diseases and Therapy, July 2020
|
| DOI | 10.1007/s40121-020-00318-1 |
| Pubmed ID | |
| Authors |
Matthew R. Davis, Erin K. McCreary, Jason M. Pogue |
X Demographics
The data shown below were collected from the profiles of 100 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 45 | 45% |
| Japan | 3 | 3% |
| Australia | 3 | 3% |
| Canada | 3 | 3% |
| Chile | 2 | 2% |
| Belgium | 2 | 2% |
| Colombia | 2 | 2% |
| Kuwait | 1 | 1% |
| South Africa | 1 | 1% |
| Other | 3 | 3% |
| Unknown | 35 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 74 | 74% |
| Scientists | 14 | 14% |
| Practitioners (doctors, other healthcare professionals) | 10 | 10% |
| Science communicators (journalists, bloggers, editors) | 2 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 89 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 13% |
| Student > Bachelor | 10 | 11% |
| Student > Master | 9 | 10% |
| Other | 8 | 9% |
| Student > Doctoral Student | 4 | 4% |
| Other | 19 | 21% |
| Unknown | 27 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 10% |
| Nursing and Health Professions | 5 | 6% |
| Biochemistry, Genetics and Molecular Biology | 5 | 6% |
| Economics, Econometrics and Finance | 2 | 2% |
| Other | 8 | 9% |
| Unknown | 32 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 63. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2020.
All research outputs
#690,483
of 25,736,439 outputs
Outputs from Infectious Diseases and Therapy
#32
of 868 outputs
Outputs of similar age
#20,751
of 431,671 outputs
Outputs of similar age from Infectious Diseases and Therapy
#3
of 23 outputs
Altmetric has tracked 25,736,439 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 868 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,671 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.